Bruce Kovner is Director & 10% at SYNTA PHARMACEUTICALS CORP (SNTA). They have made 47 open-market trades across 3 companies since 2007, most recently 2021-10-05.
CIK 0001325713
40 open-market purchases totalling $99.4M since 2007, against 7 sales. Across 7 scored buys the stock is up 9.4% at ninety days, and 3.7 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 71% | 43% |
| Avg Move | +6.8% | +6.8% | +9.4% |
| Alpha | +4.7% | +3.2% | +3.7% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SBBP | BUY | 2020-09-17 | 2020-09-21 | $2.25 | $6.6M | -5.0% | -4.1% | +22.7% |
| SBBP | BUY | 2018-12-26 | 2018-12-28 | $3.99 | $197K | +10.0% | +9.1% | +20.5% |
| SBBP | BUY | 2018-12-20 | 2018-12-21 | $3.97 | $1.3M | +15.8% | +19.6% | +37.0% |
| SBBP | BUY | 2018-08-08 | 2018-08-09 | $4.93 | $3.6M | -6.8% | -17.8% | -0.2% |
| SBBP | BUY | 2018-07-24 | 2018-07-27 | $4.83 | $2.6M | +28.3% | +18.5% | -1.1% |
| SBBP | BUY | 2018-07-19 | 2018-07-23 | $4.97 | $276K | -2.0% | +5.9% | -6.9% |
| KALA | BUY | 2017-07-20 | 2017-07-20 | $15.00 | $3.2M | +7.5% | +16.1% | -6.6% |
| SNTA | SELL | 2015-12-04 | 2015-12-08 | $0.37 | $570K | N/A | N/A | N/A |
| SNTA | SELL | 2015-12-01 | 2015-12-03 | $0.43 | $610K | N/A | N/A | N/A |
| SNTA | SELL | 2015-11-25 | 2015-11-30 | $0.48 | $1.5M | N/A | N/A | N/A |
| SNTA | SELL | 2015-11-23 | 2015-11-24 | $0.44 | $516K | N/A | N/A | N/A |
| SNTA | SELL | 2015-11-18 | 2015-11-20 | $0.49 | $738K | N/A | N/A | N/A |
| SNTA | SELL | 2015-11-13 | 2015-11-17 | $0.42 | $519K | N/A | N/A | N/A |
| SNTA | SELL | 2015-11-09 | 2015-11-12 | $0.55 | $3.0M | N/A | N/A | N/A |
| SNTA | BUY | 2015-04-06 | 2015-04-08 | $1.75 | $12.0M | N/A | N/A | N/A |
| SNTA | BUY | 2014-09-30 | 2014-10-01 | $3.08 | $924K | N/A | N/A | N/A |
| SNTA | BUY | 2014-04-11 | 2014-04-14 | $4.01 | $5.0M | N/A | N/A | N/A |
| SNTA | BUY | 2013-11-13 | 2013-11-15 | $3.75 | $18.8M | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-27 | 2013-07-01 | $4.71 | $707K | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-25 | 2013-06-27 | $4.53 | $2.3M | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-21 | 2013-06-25 | $4.39 | $1.1M | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-18 | 2013-06-20 | $4.00 | $800K | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-04 | 2013-06-06 | $4.63 | $9.3M | N/A | N/A | N/A |
| SNTA | BUY | 2012-11-12 | 2012-11-14 | $6.91 | $260K | N/A | N/A | N/A |
| SNTA | BUY | 2012-06-29 | 2012-07-02 | $5.45 | $5.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.